Other News To Note
Monday, June 24, 2013
Bellus Health Inc., of Laval, Quebec, and Thallion Pharmaceuticals Inc., of Dorval, Quebec, said Bellus agreed to acquire Thallion for about $6.3 million in cash, or about 17 cents per share (on a fully diluted basis), subject to certain adjustments, and the issuance of contingent value rights (CVRs).
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.